ALTESA
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to human health: high-consequence viral pathogens.
ALTESA
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2022-01-01
Address:
College Park, Georgia, United States
Country:
United States
Website Url:
http://www.altesabio.com
Total Employee:
1+
Status:
Active
Total Funding:
35 M USD
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Precision For Medicine
Precision for Medicine is the first global, precision-medicine, clinical research organization.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Current Employees Featured
Founder
Official Site Inspections
http://www.altesabio.com
- Host name: ec2-3-217-116-166.compute-1.amazonaws.com
- IP address: 3.217.116.166
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Altesa"
Altesa - Crunchbase Company Profile & Funding
Contact Email [email protected] Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to …See details»
Leadership | Altesa BioSciences
Our leadership team is a highly successful and uniquely experienced group of clinicians, scientists, corporate executives, and investment professionals.See details»
Opportunity | Altesa BioSciences
More than 16.4 million Americans, or 6.6% of U.S. adults, have been diagnosed with COPD. COPD is the third leading cause of death worldwide, according to the World Health …See details»
Altesa BioSciences, Inc. | LinkedIn
Altesa BioSciences, Inc. | 472 followers on LinkedIn. Developing antivirals for diseases of global concernSee details»
Altesa BioSciences - Overview, News & Similar companies
May 24, 2022 www.altesabio.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Altesa BioSciences to Initiate Clinical Trials of …See details»
Altesa BioSciences, Inc. - Drug pipelines, Patents, Clinical ... - Patsnap
Explore Altesa BioSciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, Disease Domain:Infectious Diseases ...See details»
Altesa BioSciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Altesa BioSciences, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Altesa Biosciences - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Altesa BioSciences Announces Scientific Advisory Board
Feb 28, 2022 ATLANTA--(BUSINESS WIRE)-- Altesa BioSciences, Inc., a clinical-stage biopharmaceutical company developing and commercializing novel anti-viral drugs against …See details»
Altesa BioSciences Recognizes Co-Founder and Partner …
May 25, 2022 Laura Smart, Altesa BioSciences 703 618 2108 or [email protected] Release Summary Altesa BioSciences recognizes co-founder George Painter, PhD, for major research grant that will establish a ...See details»
NR ALTESA LAUNCHES OPS 02.10.2022 final - altesabio.com
Feb 10, 2022 Organization (WHO) and Admiral in the U.S. Public Health Service Commissioned Corps – will serve as Altesa’s inaugural CEO. “When I first became aware of the incredible …See details»
Altesa BioSciences to Initiate Clinical Trials of Promising Antiviral
May 26, 2022 ATLANTA--(BUSINESS WIRE)--Altesa BioSciences, Inc. (Altesa), a clinical-stage biopharmaceutical company developing and commercializing novel antiviral drugs against …See details»
Altesa BioSciences to Initiate Clinical Trials of Promising Antiviral
May 26, 2022 ATLANTA--(BUSINESS WIRE)-- Altesa BioSciences, Inc. (Altesa), a clinical-stage biopharmaceutical company developing and commercializing novel antiviral drugs against …See details»
Altesa BioSciences, Inc., Launches Operations to ... - Business Wire
Feb 10, 2022 Laura Smart, Altesa BioSciences 703 618 2108 or [email protected] Release Summary Altesa BioSciences to develop novel anti-viral drugs against common …See details»
Vapendavir - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 Vapendavir: a HRV capsid inhibitors Drug, Initially developed by Aviragen Therapeutics, Now, its global highest R&D status is Phase 2, Mechanism: HRV capsid …See details»
Leadership - Altesa Bio
Leadership Altesa ioSciences, nc. 1 Harvard Street, College Par, A Atesacom Erica Bitten, MHA, SPHR, is an HR and Program leader with over 15 years of experience developing and …See details»
Home - English - AltraBio
Unlock the full value of your data CYTOMETRY DATA OMICS DATA MEDICAL DATA LOOKING FOR ASSISTANCE WITH ANALYZING AND INTERPRETING YOUR DATA? AltraBio is a …See details»
Leadership - Altesa Bio
Leadership Altea iSciece c arard treet Cllee ar A Alteacom Richard Whitley, MD is a member of the Altesa Scientific Advisory Board and most recently served on the Board of Directors of GileadSee details»
Altesa’s Expanded Access Policy - altesabio.com
Once notification of investigational product availability is made, physicians seeking expanded access to a Altesa investigational product on behalf of their patients should submit an inquiry …See details»